Navigation Links
Erroneous Laboratory Operation May Lead To a Cancer Drug

An error in the laboratory may pave way to the discovery of a new drug for cancer. This was disclosed by Katherine Schaefer of Rochester University Medical Center. //This may be a foundation study for treatments associated with colon, skin, liver and oesophagal cancers.

Schaefer was studying to locate therapeutic measures for swelling in Crohn’s disease and ulcerative colitis which results in intense pain and diarrhoea. Cancer cells were used as controls for this study and a compound by the name PPAR-gamma modulator was being tested. Schaefer realized that a small error in her laboratory calculation resulted in the death of the cancer cells.

She also found that PPAR-gamma had killed all the epithelial lining of the tumor cells. In the mice this compound killed colon tumor with no side effects.

According to Schaefer, mode of action of PPAR-gamma is different from the current drugs. It attacks a section of cell cytoskeleton called tubulin. While tubulin is involved in building the cell arrangement, PPAR-gamma breaks it down. This indirectly indicates that the gamma compound could actually counter the effect of tumor cells to chemotherapy.

Schaefer also intends to pursue this study further and conduct more trials with mice on the same subject.
JYT
'"/>




Page: 1

Related medicine news :

1. Watch Out For the Erroneous Readings in the Glucose Meters
2. Medicare Sends out Reimbursement Checks Erroneously
3. Laboratory Testing Can Identify Risk of Pre-Term Labor and Delivery
4. Laboratory grown vegetarian meat
5. Mexico and US border attain a new outlook due to BiNational Sustainability Laboratory
6. Laboratory Heart valve to study Heart diseases
7. NCFAD Nominated As Reference Laboratory for Bird Flu and BSE
8. British Laboratory Certifies Coke as Safe
9. India to Set Up Nicotine-Mapping Laboratory
10. A Laboratory Filtration System Kills 100 Percent Of Dangerous Microbes In Water
11. Death Of Woman Following Family Planning Operation Creates Panic
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/26/2017)... ... July 26, 2017 , ... Evergreen Healthcare Partners is ... continued efforts to provide innovative offerings to their healthcare partners. These solutions will ... dynamic, high-performing teams to address healthcare IT’s biggest challenges. , “Adding Talent Management ...
(Date:7/26/2017)... ... ... may be hard to imagine that the basic necessities that developed countries take for ... developed countries consider rare or eradicated, like measles, are still a rite of passage ... segment of "Success Files", actor Rob Lowe will introduce a new segment that will ...
(Date:7/26/2017)... ... July 26, 2017 , ... ... will host its 2017 Process Validation and Process Validation Statistics Conferences in ... to process validation lifecycle challenges faced by process validation professionals and statisticians ...
(Date:7/26/2017)... Newport Beach, CA 92660 (PRWEB) , ... ... ... of Data Loss Prevention for on-premises, off and in the cloud ; today ... intelligent detection and scientific algorithms within a simple to use control console for ...
(Date:7/26/2017)... ... July 26, 2017 , ... “We are thrilled to be partnering with Six ... schedule an appointment online in real time,” said Keith English, LocalMed CEO. “Allowing patients ... will bring more Six Month Smiles patients to their providers.” , Each month, over ...
Breaking Medicine News(10 mins):
(Date:7/13/2017)... Mich. , July 13, 2017  Centurion Medical Products, a ... its DisImpactor ® fecal impaction removal device for hospice patient ... ... Patient pain management and ... for Hospice can help alleviate patient pain while preventing unneeded emergency ...
(Date:7/11/2017)... IRVINE, Calif. , July 11, 2017 Zymo Research Corp., ... new service that can quantify biological aging in a precise manner using ... Dr. Steve Horvath , a professor of human genetics and biostatistics ... Fielding School of Public Health , Zymo Research,s proprietary DNAge ™ ... loci. ...
(Date:7/11/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) ( ... development of oral drug delivery systems, announced today that ... to schedule an End-of-Phase II meeting with Oramed for ... insulin capsule ORMD-0801 in the treatment of type 2 ... endpoints by indicating a statistically significant lowering of glucose ...
Breaking Medicine Technology: